Conservative management in a case of retained adherent placenta in a primigravida patient


  • Annal Abhay Vaidya Department of Obstetrics and Gynecology, G. S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India
  • Shruti Panchbudhe Department of Obstetrics and Gynecology, G. S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India
  • Meena Satia Department of Obstetrics and Gynecology, G. S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India



Adherent placenta, Conservative management, Methotrexate


Morbidly adherent placenta is a serious and a catastrophic pregnancy complication. In this condition, the placenta penetrates deeply inside the uterine walls and is not separated after delivery of the baby. Reporting herewith a case of a primigravida who had undergone Emergency lower segment Caesarean section at a private hospital for severe pregnancy induced hypertension with IUGR and then was referred to Tertiary Care hospital with placenta left in-situ due to non-separation of the placenta at the time of caesarean section. Conservative management was given using Methotrexate which is an anti-metabolite alternatively with Leucovorin (Folinic acid) and followed up with serial ultrasonography with Doppler for placental size and volume and beta-HCG levels which showed a decreasing trend respectively.


Chandraharan E, Rao S, Belli AM, Arulkumaran S. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012;117(2):191-4.

Konijeti R, Rajfer J and Askari A. Placenta Percreta and the Urologist. Rev Urol. 2009;11(3):173-6.

Wu S, Kocherginsky M, Hibbard JU, Abnormal placentation twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458-61.

Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for placenta accrete. Obstetr Gynecol. 1999;93(4):545-50.

Jacques SM, Qureshi F, Trent VS, Ramirez NC. Placenta accreta Mild cases diagnosed by placental examination. Int J Gynecol Pathol. 1996;15:28-33.

Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa–placenta accreta. Am J Obstetr Gynecol. 1997;177(1):210-4.

Flood KM, Said S, Geary M, Robson M, Fitzpatrick C, Malone FD. Changing trends in peripartum hysterectomy over the last 4 decades. Am J Obstet Gynecol. 2009;200(6):632e1-6

Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv. 1998;53(8):509-17.

Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound in Obstetrics and Gynecology. 2005;26(1):89-96.

Comstock CH, Love JJ, Bronsteen RA, Lee W, Vettraino IM, Huang RR. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004;190:1135-40.

ACOG Committee on Obstetric Practice Committee opinion no. 266: placenta accreta. Obstet Gynecol. 2002;99:169-70.

Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011;117:331-7.

Arnadottir BT, Hardardóttir H, Marvinsdóttir B. Case report seventeen year old primipara with placenta increta treated with methotrexate. Laeknabladid. 2008;94(7-8):549-52.

Kinoshita T, Ogawa K, Yasumizu T, Kato J. Spontaneous rupture of the uterus due to placenta percreta at 25-weeks of gestation: a case report. J Obstetr Gynecol Res. 1996;22(2):125-8.

Rajkumar B, Kumar N, Srinivasan S. Placenta percreta in primigravida, an unsuspected situation. Int J Reproduct Contracept Obstet Gynecol. 2016;3(1):239-41.






Case Reports